Abstract
The oxygen atmosphere surrounding us produces continuous oxidative stress because of the incomplete reduction of the O2 molecule. Oxidative stress mainly occurs in any system when the generation of reactive oxygen species (ROS) exceeds the system’s ability to neutralize and eliminate them. This imbalance of ROS can result from various pathways. Overproduction of ROS and their limited removal can result from mitochondrial respiratory chain, a lack of antioxidant capacity, exposure to environmental or behavioral stressors, etc. Such accumulation of ROS or oxidative stress can cause damage to all biomolecules, including lipids, proteins, and DNA. For this reason, oxidative stress has been implicated in a growing list of human diseases such as cancer, atherosclerosis, Parkinson’s disease, heart failure, myocardial infarction, Alzheimer’s disease, fragile X syndrome, etc., as well as in the aging process. Chronic heart disease is the major cause of death worldwide in the present era, and it is known that oxidative stress plays a crucial role in the morbidity and mortality due to cardiovascular disease. It is therefore very important to measure oxidative stress to check health. There are many techniques available to measure it. The major techniques include measurement of lipid peroxidation products, volatile hydrocarbons in breath, and oxidized DNA bases in urine. In this review, we will discuss potential biomarkers in cardiovascular disease and the methods of measuring oxidative stress.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lennon, S. V.; Martin, S. J.; Cotter, T. G., Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif 1991, 24 (2), 203–14.
Turko, I. V.; Marcondes, S.; Murad, F., Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase. Am J Physiol Heart Circ Physiol 2001, 281 (6), H2289–94.
Maritim, A. C.; Sanders, R. A.; Watkins, J. B., 3rd, Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003, 17 (1), 24–38.
Evans, J. L.; Goldfine, I. D.; Maddux, B. A.; Grodsky, G. M., Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002, 23 (5), 599–622.
Valko, M.; Rhodes, C. J.; Moncol, J.; Izakovic, M.; Mazur, M., Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006, 160 (1), 1–40.
Masutani, H., Oxidative stress response and signaling in hematological malignancies and HIV infection. Int J Hematol 2000, 71 (1), 25–32.
Cadenas, E.; Davies, K. J., Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 2000, 29 (3–4), 222–30.
Li, C.; Jackson, R. M., Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 2002, 282 (2), C227–41.
Halliwell, B., Antioxidants in human health and disease. Annu Rev Nutr 1996, 16, 33–50.
Conner, E. M.; Grisham, M. B., Inflammation, free radicals, and antioxidants. Nutrition 1996, 12 (4), 274–7.
Halliwell, B.; Gutteridge, J.M.C. Free radicals in biology and medicine, 3rd ed., Oxford University Press 1999.
Cadenas, E., Biochemistry of oxygen toxicity. Annu Rev Biochem 1989, 58, 79–110.
Valko, M.; Izakovic, M.; Mazur, M.; Rhodes, C. J.; Telser, J., Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004, 266 (1-2), 37–56.
Michiels, C.; Raes, M.; Toussaint, O.; Remacle, J., Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med 1994, 17 (3), 235–48.
Gupta, M.; Dobashi, K.; Greene, E. L.; Orak, J. K.; Singh, I., Studies on hepatic injury and antioxidant enzyme activities in rat subcellular organelles following in vivo ischemia and reperfusion. Mol Cell Biochem 1997, 176 (1-2), 337–47.
Squadrito, G. L.; Pryor, W. A., Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. Free Radic Biol Med 1998, 25 (4-5), 392–403.
Droge, W., Free radicals in the physiological control of cell function. Physiol Rev 2002, 82 (1), 47–95.
Dizdaroglu, M.; Jaruga, P.; Birincioglu, M.; Rodriguez, H., Free radical-induced damage to DNA: mechanisms and measurement. Free Radic Biol Med 2002, 32 (11), 1102–15.
Marnett, L. J., Oxyradicals and DNA damage. Carcinogenesis 2000, 21 (3), 361–70.
Cooke, M. S.; Evans, M. D.; Dizdaroglu, M.; Lunec, J., Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 2003, 17 (10), 1195–214.
Brown, G. C.; Borutaite, V., Nitric oxide, mitochondria, and cell death. IUBMB Life 2001, 52 (3-5), 189–95.
Inoue, M.; Sato, E. F.; Nishikawa, M.; Park, A. M.; Kira, Y.; Imada, I.; Utsumi, K., Mitochondrial generation of reactive oxygen species and its role in aerobic life. Curr Med Chem 2003, 10 (23), 2495–505.
Esterbauer, H.; Schaur, R. J.; Zollner, H., Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991, 11 (1), 81–128.
Marnett, L. J., Lipid peroxidation-DNA damage by malondialdehyde. Mutat Res 1999, 424 (1-2), 83–95.
Stadtman, E. R., Protein oxidation and aging. Science 1992, 257 (5074), 1220–4.
Stadtman, E. R., Protein oxidation in aging and age-related diseases. Ann N Y Acad Sci 2001, 928, 22–38.
Levine, R. L.; Stadtman, E. R., Oxidative modification of proteins during aging. Exp Gerontol 2001, 36 (9), 1495–502.
Oberley, L. W.; Buettner, G. R., Role of superoxide dismutase in cancer: a review. Cancer Res 1979, 39 (4), 1141–9.
Gibbons, G. H.; Dzau, V. J., Molecular therapies for vascular diseases. Science 1996, 272 (5262), 689–93.
Liao, F.; Andalibi, A.; Qiao, J. H.; Allayee, H.; Fogelman, A. M.; Lusis, A. J., Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J Clin Invest 1994, 94 (2), 877–84.
Rajagopalan, S.; Meng, X. P.; Ramasamy, S.; Harrison, D. G.; Galis, Z. S., Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996, 98 (11), 2572–9.
Griendling, K. K.; Minieri, C. A.; Ollerenshaw, J. D.; Alexander, R. W., Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994, 74 (6), 1141–8.
Keaney, J. F., Jr.; Xu, A.; Cunningham, D.; Jackson, T.; Frei, B.; Vita, J. A., Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest 1995, 95 (6), 2520–9.
Pratico, D.; Tangirala, R. K.; Rader, D. J.; Rokach, J.; FitzGerald, G. A., Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med 1998, 4 (10), 1189–92.
Tangirala, R. K.; Pratico, D.; FitzGerald, G. A.; Chun, S.; Tsukamoto, K.; Maugeais, C.; Usher, D. C.; Pure, E.; Rader, D. J., Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E. J Biol Chem 2001, 276 (1), 261–6.
Shaish, A.; George, J.; Gilburd, B.; Keren, P.; Levkovitz, H.; Harats, D., Dietary beta-carotene and alpha-tocopherol combination does not inhibit atherogenesis in an ApoE-deficient mouse model. Arterioscler Thromb Vasc Biol 1999, 19 (6), 1470–5.
Terentis, A. C.; Thomas, S. R.; Burr, J. A.; Liebler, D. C.; Stocker, R., Vitamin E oxidation in human atherosclerotic lesions. Circ Res 2002, 90 (3), 333–9.
Napoli, C.; Witztum, J. L.; Calara, F.; de Nigris, F.; Palinski, W., Maternal hypercholesterolemia enhances atherogenesis in normocholesterolemic rabbits, which is inhibited by antioxidant or lipid-lowering intervention during pregnancy: an experimental model of atherogenic mechanisms in human fetuses. Circ Res 2000, 87 (10), 946–52.
Febbraio, M.; Podrez, E. A.; Smith, J. D.; Hajjar, D. P.; Hazen, S. L.; Hoff, H. F.; Sharma, K.; Silverstein, R. L., Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 2000, 105 (8), 1049–56.
Cyrus, T.; Witztum, J. L.; Rader, D. J.; Tangirala, R.; Fazio, S.; Linton, M. F.; Funk, C. D., Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest 1999, 103 (11), 1597–604.
Hsich, E.; Segal, B. H.; Pagano, P. J.; Rey, F. E.; Paigen, B.; Deleonardis, J.; Hoyt, R. F.; Holland, S. M.; Finkel, T., Vascular effects following homozygous disruption of p47(phox) : An essential component of NADPH oxidase. Circulation 2000, 101 (11), 1234–6.
Kirk, E. A.; Dinauer, M. C.; Rosen, H.; Chait, A.; Heinecke, J. W.; LeBoeuf, R. C., Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2000, 20 (6), 1529–35.
Barry-Lane, P. A.; Patterson, C.; van der Merwe, M.; Hu, Z.; Holland, S. M.; Yeh, E. T.; Runge, M. S., p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest 2001, 108 (10), 1513–22.
Ohara, Y.; Peterson, T. E.; Harrison, D. G., Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993, 91 (6), 2546–51.
Warnholtz, A.; Nickenig, G.; Schulz, E.; Macharzina, R.; Brasen, J. H.; Skatchkov, M.; Heitzer, T.; Stasch, J. P.; Griendling, K. K.; Harrison, D. G.; Bohm, M.; Meinertz, T.; Munzel, T., Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 1999, 99 (15), 2027–33.
Miller, V. M.; Aarhus, L. L.; Vanhoutte, P. M., Modulation of endothelium-dependent responses by chronic alterations of blood flow. Am J Physiol 1986, 251 (3 Pt 2), H520–7.
Laursen, J. B.; Rajagopalan, S.; Galis, Z.; Tarpey, M.; Freeman, B. A.; Harrison, D. G., Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 1997, 95 (3), 588–93.
Weiss, D.; Kools, J. J.; Taylor, W. R., Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Circulation 2001, 103 (3), 448–54.
Li, D. Y.; Zhang, Y. C.; Philips, M. I.; Sawamura, T.; Mehta, J. L., Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation. Circ Res 1999, 84 (9), 1043–9.
Poltronieri, R.; Cevese, A.; Sbarbati, A., Protective effect of selenium in cardiac ischemia and reperfusion. Cardioscience 1992, 3 (3), 155–60.
Gross, G. J.; Farber, N. E.; Hardman, H. F.; Warltier, D. C., Beneficial actions of superoxide dismutase and catalase in stunned myocardium of dogs. Am J Physiol 1986, 250 (3 Pt 2), H372–7.
Opie, L. H., Reperfusion injury and its pharmacologic modification. Circulation 1989, 80 (4), 1049–62.
Kloner, R. A.; Przyklenk, K.; Whittaker, P., Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues. Circulation 1989, 80 (5), 1115–27.
Kilgore, K. S.; Lucchesi, B. R., Reperfusion injury after myocardial infarction: the role of free radicals and the inflammatory response. Clin Biochem 1993, 26 (5), 359–70.
Kramer, J. H.; Arroyo, C. M.; Dickens, B. F.; Weglicki, W. B., Spin-trapping evidence that graded myocardial ischemia alters post-ischemic superoxide production. Free Radic Biol Med 1987, 3 (2), 153–9.
Garlick, P. B.; Davies, M. J.; Hearse, D. J.; Slater, T. F., Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res 1987, 61 (5), 757–60.
Zweier, J. L.; Flaherty, J. T.; Weisfeldt, M. L., Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA 1987, 84 (5), 1404–7.
Godin, D. V.; Garnett, M. E., Altered antioxidant status in the ischemic/reperfused rabbit myocardium: effects of allopurinol. Can J Cardiol 1989, 5 (7), 365–71.
Chatham, J. C.; Seymour, A. L.; Harmsen, E.; Radda, G. K., Depletion of myocardial glutathione: its effects on heart function and metabolism during ischaemia and reperfusion. Cardiovasc Res 1988, 22 (11), 833–9.
Leichtweis, S.; Ji, L. L., Glutathione deficiency intensifies ischaemia-reperfusion induced cardiac dysfunction and oxidative stress. Acta Physiol Scand 2001, 172 (1), 1–10.
Pyles, L. A.; Fortney, J. E.; Kudlak, J. J.; Gustafson, R. A.; Einzig, S., Plasma antioxidant depletion after cardiopulmonary bypass in operations for congenital heart disease. J Thorac Cardiovasc Surg 1995, 110 (1), 165–71.
Pietri, S.; Culcasi, M.; Stella, L.; Cozzone, P. J., Ascorbyl free radical as a reliable indicator of free-radical-mediated myocardial ischemic and post-ischemic injury. A real-time continuous-flow ESR study. Eur J Biochem 1990, 193 (3), 845–54.
Ko, K. M.; Garnett, M. E.; Godin, D. V., Altered antioxidant status in ischemic/reperfused rabbit myocardium: reperfusion time-course study. Can J Cardiol 1990, 6 (7), 299–304.
Nishinaka, Y.; Sugiyama, S.; Yokota, M.; Saito, H.; Ozawa, T., The effects of a high dose of ascorbate on ischemia-reperfusion-induced mitochondrial dysfunction in canine hearts. Heart Vessels 1992, 7 (1), 18–23.
Alberola, A.; Such, L.; Gil, F.; Zaragoza, R.; Morcillo, E. J., Protective effect of N-acetylcysteine on ischaemia-induced myocardial damage in canine heart. Naunyn Schmiedebergs Arch Pharmacol 1991, 343 (5), 505–10.
Steare, S. E.; Yellon, D. M., The potential for endogenous myocardial antioxidants to protect the myocardium against ischaemia-reperfusion injury: refreshing the parts exogenous antioxidants cannot reach? J Mol Cell Cardiol 1995, 27 (1), 65–74.
Ho, Y. S.; Magnenat, J. L.; Gargano, M.; Cao, J., The nature of antioxidant defense mechanisms: a lesson from transgenic studies. Environ Health Perspect 1998, 106 Suppl 5, 1219–28.
Li, G.; Chen, Y.; Saari, J. T.; Kang, Y. J., Catalase-overexpressing transgenic mouse heart is resistant to ischemia-reperfusion injury. Am J Physiol 1997, 273 (3 Pt 2), H1090–5.
Asimakis, G. K.; Lick, S.; Patterson, C., Postischemic recovery of contractile function is impaired in SOD2(+/-) but not SOD1(+/-) mouse hearts. Circulation 2002, 105 (8), 981–6.
Yoshida, T.; Maulik, N.; Engelman, R. M.; Ho, Y. S.; Das, D. K., Targeted disruption of the mouse Sod I gene makes the hearts vulnerable to ischemic reperfusion injury. Circ Res 2000, 86 (3), 264–9.
Wang, P.; Chen, H.; Qin, H.; Sankarapandi, S.; Becher, M. W.; Wong, P. C.; Zweier, J. L., Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postischemic injury. Proc Natl Acad Sci USA 1998, 95 (8), 4556–60.
Chen, E. P.; Bittner, H. B.; Davis, R. D.; Van Trigt, P.; Folz, R. J., Physiologic effects of extracellular superoxide dismutase transgene overexpression on myocardial function after ischemia and reperfusion injury. J Thorac Cardiovasc Surg 1998, 115 (2), 450–8; discussion 458–9.
Chen, E. P.; Bittner, H. B.; Davis, R. D.; Folz, R. J.; Van Trigt, P., Extracellular superoxide dismutase transgene overexpression preserves postischemic myocardial function in isolated murine hearts. Circulation 1996, 94 (9 Suppl), II412–7.
Das, D. K.; Dillmann, W.; Ho, Y. S.; Lin, K. M.; Gloss, B. R., Using genetically engineered mice to study myocardial ischemia-reperfusion injury. Methods Enzymol 2002, 353, 346–65.
Sharp, B. R.; Jones, S. P.; Rimmer, D. M.; Lefer, D. J., Differential response to myocardial reperfusion injury in eNOS-deficient mice. Am J Physiol Heart Circ Physiol 2002, 282 (6), H2422–6.
Jones, S. P.; Hoffmeyer, M. R.; Sharp, B. R.; Ho, Y. S.; Lefer, D. J., Role of intracellular antioxidant enzymes after in vivo myocardial ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2003, 284 (1), H277–82.
Kurose, I.; Granger, D. N., Evidence implicating xanthine oxidase and neutrophils in reperfusion-induced microvascular dysfunction. Ann N Y Acad Sci 1994, 723, 158–79.
Levraut, J.; Iwase, H.; Shao, Z. H.; Vanden Hoek, T. L.; Schumacker, P. T., Cell death during ischemia: relationship to mitochondrial depolarization and ROS generation. Am J Physiol Heart Circ Physiol 2003, 284 (2), H549–58.
Petrosillo, G.; Ruggiero, F. M.; Di Venosa, N.; Paradies, G., Decreased complex III activity in mitochondria isolated from rat heart subjected to ischemia and reperfusion: role of reactive oxygen species and cardiolipin. FASEB J 2003, 17 (6), 714–6.
Vanden Hoek, T. L.; Shao, Z.; Li, C.; Schumacker, P. T.; Becker, L. B., Mitochondrial electron transport can become a significant source of oxidative injury in cardiomyocytes. J Mol Cell Cardiol 1997, 29 (9), 2441–50.
Ruuge, E. K.; Kashkarov, K. P.; Lakomkin, V. L.; Timoshin, A. A.; Vasil’eva, E. V., The redox state of coenzyme Q10 in mitochondrial respiratory chain and oxygen-derived free radical generation in cardiac cells. Mol Aspects Med 1997, 18 Suppl, S41–50.
Moncada, S.; Higgs, A., The l-arginine-nitric oxide pathway. N Engl J Med 1993, 329 (27), 2002–12.
Gilmont, R. R.; Dardano, A.; Young, M.; Engle, J. S.; Adamson, B. S.; Smith, D. J., Jr.; Rees, R. S., Effects of glutathione depletion on oxidant-induced endothelial cell injury. J Surg Res 1998, 80 (1), 62–8.
Aktan, A. O.; Gulluoglu, B. M.; Cingi, A., Prospective multicentre trials in developing countries: willingness of surgeons to participate. Eur J Surg 1998, 164 (10), 733–5.
Ferrari, R.; Ceconi, C.; Curello, S.; Cargnoni, A.; Condorelli, E.; Belloli, S.; Albertini, A.; Visioli, O., Metabolic changes during post-ischaemic reperfusion. J Mol Cell Cardiol 1988, 20 Suppl 2, 119–33.
Schafer, C.; Ladilov, Y.; Inserte, J.; Schafer, M.; Haffner, S.; Garcia-Dorado, D.; Piper, H. M., Role of the reverse mode of the Na+/Ca2+ exchanger in reoxygenation-induced cardiomyocyte injury. Cardiovasc Res 2001, 51 (2), 241–50.
Piper, H. M.; Abdallah, Y.; Schafer, C., The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res 2004, 61 (3), 365–71.
Waples, M. J.; Belzer, F. O.; Uehling, D. T., Living donor nephrectomy: a 20-year experience. Urology 1995, 45 (2), 207–10.
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993, 329 (14), 977–86.
Brownlee, M., Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414 (6865), 813–20.
Maddux, B. A.; See, W.; Lawrence, J. C., Jr.; Goldfine, A. L.; Goldfine, I. D.; Evans, J. L., Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of alpha-lipoic acid. Diabetes 2001, 50 (2), 404–10.
Hirsch, I. B.; Brownlee, M., Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications 2005, 19 (3), 178–81.
Hirsch, I. B., Intensifying insulin therapy in patients with type 2 diabetes mellitus. Am J Med 2005, 118 Suppl 5A, 21S–6S.
Quagliaro, L.; Piconi, L.; Assaloni, R.; Martinelli, L.; Motz, E.; Ceriello, A., Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 2003, 52 (11), 2795–804.
Schiekofer, S.; Andrassy, M.; Chen, J.; Rudofsky, G.; Schneider, J.; Wendt, T.; Stefan, N.; Humpert, P.; Fritsche, A.; Stumvoll, M.; Schleicher, E.; Haring, H. U.; Nawroth, P. P.; Bierhaus, A., Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaB in PBMCs. Diabetes 2003, 52 (3), 621–33.
Jones, S. C.; Saunders, H. J.; Qi, W.; Pollock, C. A., Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells. Diabetologia 1999, 42 (9), 1113–9.
Santilli, F.; Cipollone, F.; Mezzetti, A.; Chiarelli, F., The role of nitric oxide in the development of diabetic angiopathy. Horm Metab Res 2004, 36 (5), 319–35.
Giugliano, D.; Marfella, R.; Coppola, L.; Verrazzo, G.; Acampora, R.; Giunta, R.; Nappo, F.; Lucarelli, C.; D’Onofrio, F., Vascular effects of acute hyperglycemia in humans are reversed by l-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 1997, 95 (7), 1783–90.
Du, X. L.; Edelstein, D.; Dimmeler, S.; Ju, Q.; Sui, C.; Brownlee, M., Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 2001, 108 (9), 1341–8.
Beckman, J. S.; Koppenol, W. H., Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996, 271 (5 Pt 1), C1424–37.
Spitaler, M. M.; Graier, W. F., Vascular targets of redox signalling in diabetes mellitus. Diabetologia 2002, 45 (4), 476–94.
Januszewski, A. S.; Alderson, N. L.; Metz, T. O.; Thorpe, S. R.; Baynes, J. W., Role of lipids in chemical modification of proteins and development of complications in diabetes. Biochem Soc Trans 2003, 31 (Pt 6), 1413–6.
Cosentino, F.; Hishikawa, K.; Katusic, Z. S.; Luscher, T. F., High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997, 96 (1), 25–8.
Esterbauer, H.; Gebicki, J.; Puhl, H.; Jurgens, G., The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992, 13 (4), 341–90.
Spiteller, G., Linoleic acid peroxidation – the dominant lipid peroxidation process in low density lipoprotein – and its relationship to chronic diseases. Chem Phys Lipids 1998, 95 (2), 105–62.
Baynes, J. W.; Thorpe, S. R., Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 2000, 28 (12), 1708–16.
Jenkins, A. J.; Best, J. D.; Klein, R. L.; Lyons, T. J., ‘Lipoproteins, glycoxidation and diabetic angiopathy’. Diabetes Metab Res Rev 2004, 20 (5), 349–68.
Palinski, W.; Rosenfeld, M. E.; Yla-Herttuala, S.; Gurtner, G. C.; Socher, S. S.; Butler, S. W.; Parthasarathy, S.; Carew, T. E.; Steinberg, D.; Witztum, J. L., Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 1989, 86 (4), 1372–6.
Steinberg, D., Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland. Circulation 1992, 85 (6), 2337–44.
Refat, M.; Moore, T. J.; Kazui, M.; Risby, T. H.; Perman, J. A.; Schwarz, K. B., Utility of breath ethane as a noninvasive biomarker of vitamin E status in children. Pediatr Res 1991, 30 (5), 396–403.
Gutteridge, J. M.; Tickner, T. R., The characterisation of thiobarbituric acid reactivity in human plasma and urine. Anal Biochem 1978, 91 (1), 250–7.
Ekstrom, T.; Warholm, M.; Kronevi, T.; Hogberg, J., Recovery of malondialdehyde in urine as a 2,4-dinitrophenylhydrazine derivative after exposure to chloroform or hydroquinone. Chem Biol Interact 1988, 67 (1-2), 25–31.
Boyd, N. F.; McGuire, V., Evidence of lipid peroxidation in premenopausal women with mammographic dysplasia. Cancer Lett 1990, 50 (1), 31–7.
Dhanakoti, S. N.; Draper, H. H., Response of urinary malondialdehyde to factors that stimulate lipid peroxidation in vivo. Lipids 1987, 22 (9), 643–6.
Liou, S. H.; Jacobson-Kram, D.; Poirier, M. C.; Nguyen, D.; Strickland, P. T.; Tockman, M. S., Biological monitoring of fire fighters: sister chromatid exchange and polycyclic aromatic hydrocarbon-DNA adducts in peripheral blood cells. Cancer Res 1989, 49 (17), 4929–35.
Leanderson, P.; Tagesson, C., Rapid and sensitive detection of hydroxyl radicals formed by activated neutrophils in the presence of chelated iron: hydroxylation of deoxyguanosine to 8-hydroxydeoxyguanosine. Agents Actions 1992, 36 (1-2), 50–7.
Shigenaga, M. K.; Park, J. W.; Cundy, K. C.; Gimeno, C. J.; Ames, B. N., In vivo oxidative DNA damage: measurement of 8-hydroxy-2’-deoxyguanosine in DNA and urine by high-performance liquid chromatography with electrochemical detection. Methods Enzymol 1990, 186, 521–30.
Gomes, M.; Santella, R. M., Immunologic methods for the detection of benzo[a]pyrene metabolites in urine. Chem Res Toxicol 1990, 3 (4), 307–10.
Cundy, K. C.; Kohen, R.; Ames, B. N., Determination of 8-hydroxydeoxyguanosine in human urine: a possible assay for in vivo oxidative DNA damage. Basic Life Sci 1988, 49, 479–82.
Lemoyne, M.; Van Gossum, A.; Kurian, R.; Ostro, M.; Axler, J.; Jeejeebhoy, K. N., Breath pentane analysis as an index of lipid peroxidation: a functional test of vitamin E status. Am J Clin Nutr 1987, 46 (2), 267–72.
Morita, S.; Snider, M. T.; Inada, Y., Increased N-pentane excretion in humans: a consequence of pulmonary oxygen exposure. Anesthesiology 1986, 64 (6), 730–3.
Buhl, R.; Jaffe, H. A.; Holroyd, K. J.; Wells, F. B.; Mastrangeli, A.; Saltini, C.; Cantin, A. M.; Crystal, R. G., Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 1989, 2 (8675), 1294–8.
Hughes, H.; Jaeschke, H.; Mitchell, J. R., Measurement of oxidant stress in vivo. Methods Enzymol 1990, 186, 681–5.
Sies, H.; Akerboom, T. P., Glutathione disulfide (GSSG) efflux from cells and tissues. Methods Enzymol 1984, 105, 445–51.
Wayner, D. D.; Burton, G. W.; Ingold, K. U.; Barclay, L. R.; Locke, S. J., The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim Biophys Acta 1987, 924 (3), 408–19.
Begin, M. E.; Ells, G.; Horrobin, D. F., Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. J Natl Cancer Inst 1988, 80 (3), 188–94.
Gonzalez, M. J., Fish oil, lipid peroxidation and mammary tumor growth. J Am Coll Nutr 1995, 14 (4), 325–35.
Zieba, M.; Nowak, D.; Suwalski, M.; Piasecka, G.; Grzelewska-Rzymowska, I.; Tyminska, K.; Kroczynska-Bednarek, J.; Kwiatkowska, S., Enhanced lipid peroxidation in cancer tissue homogenates in non-small cell lung cancer. Monaldi Arch Chest Dis 2001, 56 (2), 110–4.
Cordis, G. A.; Maulik, N.; Das, D. K., Detection of oxidative stress in heart by estimating the dinitrophenylhydrazine derivative of malonaldehyde. J Mol Cell Cardiol 1995, 27 (8), 1645–53.
Habib, M. P.; Clements, N. C.; Garewal, H. S., Cigarette smoking and ethane exhalation in humans. Am J Respir Crit Care Med 1995, 151 (5), 1368–72.
Halliwell, B., Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward? Cardiovasc Res 2000, 47 (3), 410–8.
Roberts, L. J.; Morrow, J. D., Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000, 28 (4), 505–13.
Morrow, J. D.; Hill, K. E.; Burk, R. F.; Nammour, T. M.; Badr, K. F.; Roberts, L. J., 2nd, A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990, 87 (23), 9383–7.
Morrow, J. D.; Awad, J. A.; Boss, H. J.; Blair, I. A.; Roberts, L. J., 2nd, Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA 1992, 89 (22), 10721–5.
Morrow, J. D.; Roberts, L. J., The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 1997, 36 (1), 1–21.
Floyd, R. A.; Watson, J. J.; Wong, P. K.; Altmiller, D. H.; Rickard, R. C., Hydroxyl free radical adduct of deoxyguanosine: sensitive detection and mechanisms of formation. Free Radic Res Commun 1986, 1 (3), 163–72.
Teixeira, A. J.; Gommers-Ampt, J. H.; Van de Werken, G.; Westra, J. G.; Stavenuiter, J. F.; de Jong, A. P., Method for the analysis of oxidized nucleosides by gas chromatography/mass spectrometry. Anal Biochem 1993, 214 (2), 474–83.
Halliwell, B., Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res 1996, 25 (1), 57–74.
Loft, S.; Vistisen, K.; Ewertz, M.; Tjonneland, A.; Overvad, K.; Poulsen, H. E., Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis 1992, 13 (12), 2241–7.
Cordis, G. A.; Maulik, G.; Bagchi, D.; Riedel, W.; Das, D. K., Detection of oxidative DNA damage to ischemic reperfused rat hearts by 8-hydroxydeoxyguanosine formation. J Mol Cell Cardiol 1998, 30 (10), 1939–44.
Zhang, L.; Looney, C. G.; Qi, W. N.; Chen, L. E.; Seaber, A. V.; Stamler, J. S.; Urbaniak, J. R., Reperfusion injury is reduced in skeletal muscle by inhibition of inducible nitric oxide synthase. J Appl Physiol 2003, 94 (4), 1473–8.
Vanden Hoek, T. L.; Li, C.; Shao, Z.; Schumacker, P. T.; Becker, L. B., Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol 1997, 29 (9), 2571–83.
Vasquez-Vivar, J.; Kalyanaraman, B.; Martasek, P.; Hogg, N.; Masters, B. S.; Karoui, H.; Tordo, P.; Pritchard, K. A., Jr., Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 1998, 95 (16), 9220–5.
Vicaut, E.; Montalescot, G.; Hou, X.; Stucker, O.; Teisseire, B., Arteriolar vasoconstriction and tachyphylaxis with intraarterial angiotensin II. Microvasc Res 1989, 37 (1), 28–41.
Kuwahara, K.; Oizumi, N.; Fujisawa, S.; Tanito, M.; Ohira, A., Carteolol hydrochloride protects human corneal epithelial cells from UVB-induced damage in vitro. Cornea 2005, 24 (2), 213–20.
Cathcart, R.; Schwiers, E.; Ames, B. N., Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay. Anal Biochem 1983, 134 (1), 111–6.
Bass, D. A.; Parce, J. W.; Dechatelet, L. R.; Szejda, P.; Seeds, M. C.; Thomas, M., Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 1983, 130 (4), 1910–7.
Royall, J. A.; Ischiropoulos, H., Evaluation of 2’,7’-dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells. Arch Biochem Biophys 1993, 302 (2), 348–55.
Rao, K. M.; Padmanabhan, J.; Kilby, D. L.; Cohen, H. J.; Currie, M. S.; Weinberg, J. B., Flow cytometric analysis of nitric oxide production in human neutrophils using dichlorofluorescein diacetate in the presence of a calmodulin inhibitor. J Leukoc Biol 1992, 51 (5), 496–500.
Kooy, N. W.; Royall, J. A.; Ischiropoulos, H., Oxidation of 2’,7’-dichlorofluorescin by peroxynitrite. Free Radic Res 1997, 27 (3), 245–54.
Landmesser, U.; Dikalov, S.; Price, S. R.; McCann, L.; Fukai, T.; Holland, S. M.; Mitch, W. E.; Harrison, D. G., Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 2003, 111 (8), 1201–9.
Guzik, T. J.; Mussa, S.; Gastaldi, D.; Sadowski, J.; Ratnatunga, C.; Pillai, R.; Channon, K. M., Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002, 105 (14), 1656–62.
Gongora, M. C.; Qin, Z.; Laude, K.; Kim, H. W.; McCann, L.; Folz, J. R.; Dikalov, S.; Fukai, T.; Harrison, D. G., Role of extracellular superoxide dismutase in hypertension. Hypertension 2006, 48 (3), 473–81.
Dudley, S. C., Jr.; Hoch, N. E.; McCann, L. A.; Honeycutt, C.; Diamandopoulos, L.; Fukai, T.; Harrison, D. G.; Dikalov, S. I.; Langberg, J., Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation 2005, 112 (9), 1266–73.
Eskiocak, S.; Gozen, A. S.; Yapar, S. B.; Tavas, F.; Kilic, A. S.; Eskiocak, M., Glutathione and free sulphydryl content of seminal plasma in healthy medical students during and after exam stress. Hum Reprod 2005, 20 (9), 2595–600.
Zhang, H.; Joseph, J.; Vasquez-Vivar, J.; Karoui, H.; Nsanzumuhire, C.; Martasek, P.; Tordo, P.; Kalyanaraman, B., Detection of superoxide anion using an isotopically labeled nitrone spin trap: potential biological applications. FEBS Lett 2000, 473 (1), 58–62.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Mukherjee, S., Das, D.K. (2011). Oxidative Stress in Cardiovascular Disease: Potential Biomarkers and Their Measurements. In: Basu, S., Wiklund, L. (eds) Studies on Experimental Models. Oxidative Stress in Applied Basic Research and Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-956-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-60761-956-7_6
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-955-0
Online ISBN: 978-1-60761-956-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)